Claire Mann
Adult Health · Frisco, CONPI 1427520469
Payments from drug & device makers
Across 91 payments — averaging $23.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$888
- Johnson & Johnson$208
- Incyte Corporation$146
- UCB, Inc.$145
- Lilly USA, LLC$116
- Sun Pharmaceutical Industries Inc.$105
- plus $536 from 12 others
What the payments were for
- Food & beverage$1,96191%
- Education$1839%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 40 | $888 |
| Johnson & Johnson | 6 | $208 |
| Incyte Corporation | 7 | $146 |
| UCB, Inc. | 5 | $145 |
| Lilly USA, LLC | 6 | $116 |
| Sun Pharmaceutical Industries Inc. | 2 | $105 |
| Novartis | 4 | $76 |
| Regeneron Healthcare Solutions, Inc. | 2 | $72 |
| Sanofi | 3 | $71 |
| Galderma Laboratories, L.p. | 4 | $62 |
| Solta Medical, A Division Of Bausch Health US, LLC | 3 | $59 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $48 |
| Biofrontera Inc. | 1 | $33 |
| LEO Pharma Inc. | 2 | $31 |
| E.r. Squibb & Sons, L.L.C. | 1 | $26 |
| Amgen | 1 | $25 |
| Botanix SB Inc | 1 | $18 |
| Pfizer | 1 | $16 |
How this compares
$2,144 in reported general payments places this provider in the 80th percentile of 430 adult health providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 12 | $49,572 |
| Doxycycline Ir-DrDoxycycline Monohydrate | 15 | $10,611 |
| Fluorouracil | 87 | $5,813 |
| Clobetasol Propionate | 37 | $1,773 |
| Ketoconazole | 64 | $908 |
| Doxycycline Hyclate | 34 | $765 |
| Triamcinolone Acetonide | 70 | $737 |
| ValacyclovirValacyclovir Hcl | 23 | $539 |
| Mupirocin | 12 | $119 |
| Hydrocortisone | 17 | $83 |
Paid to pharmacies, not to this prescriber.
Other adult health in Frisco
- Donna McGregorAurora$141K
- Stefanie EymarAurora$36K
- Ellie TitarenkoArvada$32K
- Jamie ThompsonColorado Springs$31K
- Laura PetersAurora$30K
- Toni StandleyDenver$23K
- Alexandra GravesAurora$18K
- Lorna AllenAurora$17K
- Keri HalsemaAurora$17K
- Sharon GoldenGrand Junction$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.